Robbins llp reminds investors of the pending class action against cassava sciences, inc. and urges sava stockholders to contact the firm for information

San diego, jan. 06, 2025 (globe newswire) -- robbins llp reminds investors that a class action was filed against cassava sciences, inc. (nasdaq: sava) for wrongdoing between february 7, 2024 and november 24, 2024. cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
sava Ratings Summary
sava Quant Ranking